3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
2
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Fibrosis
2
Colorectal Neoplasms
2
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-small Cell Lung Cancers
1
Neuritis
1
Mucositis
1
Hodgkin Disease
1
Erectile Dysfunction
1
Colonic Neoplasms
1
Capsular Contractures
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Pentoxifylline
2
Blood Specimen Collection
2
contrast agent BR1
1
alpha-Tocopherol
1
Tocopherols
1
Spermine Synthase
1
Sonazoid
1
Propofol
1
Probiotics
1
N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide
1
Mass Screening
1
Iodides
1
Hyperbaric Oxygenation
1
Hematologic Tests
1
Gemcitabine
1
Diet, Mediterranean
1
Dexmedetomidine
1
Clinical Protocols
1
BCG Vaccine
1
Arthroplasty, Replacement, Knee
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Fibrosis
×
Pentoxifylline
×
Clear all
NCT02898376
2018-08-08
FIBROTHERME
Institut de Cancérologie de Lorraine
Phase 3
Unknown
142 enrolled
NCT01822405
2013-04-02
ORT-OXI-2009
Hospital Universitario de Canarias
Phase 2
Unknown
42 enrolled